Overview
Status
Active
Registry date
2019-07-31
Share capital
5,000.00 PLN
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 92 days for 2021).
- 202518/07/2026
- 202402/07/2025
- 202317/07/2024
- 202215/07/2023
- 202115/10/2022
- 202012/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Trademarks
BAD Landeck currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2019.
| Mark | Protected until | |
|---|---|---|
| Mark without a word element | – |
Authorized Representatives
Grzegorz Gajowniczekage 46 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Grzegorz Gajowniczekage 46 | 51 | $688.82 | 51% |
Jarosław Roman Noworolage 67 | 49 | $661.80 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | STAROSTA KŁODZKI |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl | ||
| Astrofoodssp. z o.o. | – | astrofarms.space |
FAQ
The main business activity of BAD Landeck focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 31, 2019.
The headquarters is located at: ul. Kolejowa 6, 57-540 Lądek-Zdrój.
The management board consists of: Grzegorz Gajowniczek (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-20